Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Optimizing BET Assays with (-)-JQ1: The Gold-Standard Contro
2026-06-03
(-)-JQ1, the definitive JQ1 stereoisomer, empowers epigenetics and cancer biology researchers to distinguish true BET bromodomain inhibition from off-target effects. This article details advanced workflows, protocol upgrades, and troubleshooting strategies to maximize rigor when deploying (-)-JQ1 from APExBIO as an inactive control.
-
Octyl-α-ketoglutarate in HIF-1α Regulation: Lab Workflows &
2026-06-03
Octyl-α-ketoglutarate offers researchers a robust tool to manipulate intracellular α-KG levels, enabling precise modulation of the hypoxia signaling pathway. Its cell-permeable, stable formulation from APExBIO streamlines experimental design in metabolic and cancer research, particularly for dissecting IDH mutation effects and TCA cycle dysfunction.
-
Cefoperazone Sodium Salt: Antibacterial Activity & Lab Proto
2026-06-02
Cefoperazone sodium salt stands out for robust β-lactamase stability and reproducibility in in vitro antimicrobial assays, making it a gold-standard for profiling gram-negative resistance. This article delivers actionable workflows and troubleshooting insights grounded in benchmark comparative studies.
-
Propranolol: Applied Workflows for Emotional Memory & Hypert
2026-06-02
Propranolol, a non-selective β-adrenergic receptor blocker, is a cornerstone for cardiovascular regulation and emotional memory modulation research. This guide details advanced experimental workflows, troubleshooting strategies, and key protocol parameters to achieve reproducible, clinically relevant outcomes with APExBIO’s Propranolol.
-
Abiraterone Acetate: CYP17 Inhibitor Workflows in Prostate C
2026-06-01
Abiraterone acetate enables precise CYP17 inhibition for advanced prostate cancer research, powering both 2D and innovative 3D model systems. This article delivers actionable protocols, troubleshooting insights, and a translational outlook grounded in recent evidence.
-
Direct Mouse Genotyping Kit: High-Throughput PCR from Mouse
2026-06-01
The Direct Mouse Genotyping Kit streamlines PCR amplification from mouse tissue, eliminating traditional DNA purification and reducing sample-to-genotype time. This article details optimized protocols, advanced use-cases in translational research, and troubleshooting strategies for reliable high-throughput genotyping.
-
Propranolol: Applied Protocols for Emotional Memory and Card
2026-05-31
Propranolol, a non-selective β-adrenergic receptor blocker, enables nuanced control in experimental cardiovascular and neurobehavioral models. This guide translates bench protocols into actionable workflows, highlighting troubleshooting insights and comparative advantages for cutting-edge research.
-
β-Elemene: Advanced Mechanistic Insights for Neuroprotection
2026-05-30
Explore the unique mechanisms of β-Elemene in neuroprotection and adipogenesis inhibition. This in-depth article provides advanced analysis on β-Elemene's PI3K/AKT/mTOR and AMPK pathway modulation, offering practical insights for biomedical research.
-
Biotin (Vitamin B7): Mechanistic Integration in Carboxylase
2026-05-29
Explore the multifaceted roles of Biotin (Vitamin B7) as a coenzyme for carboxylases and as a cornerstone for high-fidelity biotinylation in molecular research. This article uniquely dissects mechanistic insights and workflow-critical innovations, offering new depth for scientists utilizing Biotin in protein labeling and metabolic pathway studies.
-
GSK621: AMPK Agonist Unveiling Immunometabolic Checkpoints
2026-05-29
Explore how GSK621, a potent AMPK agonist, advances immunometabolic research and acute myeloid leukemia studies. This article uniquely connects recent mechanistic insights on macrophage reprogramming, offering practical guidance for assay design.
-
BIBP 3226 trifluoroacetate: Precision in NPY/NPFF System Res
2026-05-28
BIBP 3226 trifluoroacetate empowers researchers to dissect the NPY/NPFF axis in anxiety, analgesia, and cardiovascular regulation. Leveraging recent breakthroughs in adipose-neural signaling, this APExBIO tool enables robust, reproducible workflows for mechanistic and translational discovery.
-
Myriocin: Applied Serine Palmitoyltransferase Inhibitor Work
2026-05-28
Myriocin empowers researchers to dissect sphingolipid metabolism and cell cycle regulation with nanomolar precision. This guide delivers actionable protocols, troubleshooting strategies, and workflow enhancements for oncology and immunology labs leveraging APExBIO’s gold-standard serine palmitoyltransferase inhibitor.
-
Structural Mechanisms of TRPM3 Modulation by Neurosteroids a
2026-05-27
This study unveils high-resolution cryo-EM structures of TRPM3 ion channels bound to neurosteroids and the anticonvulsant primidone, providing critical insight into ligand-specific regulation and disease mutation impact. These findings clarify how endogenous and therapeutic agents modulate TRPM3 gating, advancing the groundwork for targeted pain and neurodevelopmental disorder therapies.
-
Dihydroethidium in Ferroptosis and ALI: Redox Precision for
2026-05-27
Explore how Dihydroethidium (DHE, hydroethidine) empowers translational researchers to dissect superoxide-driven mechanisms in acute lung injury (ALI) and ferroptosis, bridging mechanistic insight with strategic workflow guidance. This article synthesizes recent breakthroughs in the Keap1-Nrf2/GPX4 axis and offers actionable protocol parameters, competitive benchmarking, and a forward-looking perspective for oxidative stress assays. Contextual product insights and internal cross-linking establish new benchmarks for redox biology research.
-
Enzyme and Transporter-Mediated DDI Risks in 2022 FDA Antifu
2026-05-26
This article analyzes a recent comprehensive review of drug-drug interaction (DDI) risks for small-molecule agents approved by the FDA in 2022, focusing on enzyme and transporter mechanisms. The findings highlight Oteseconazole’s (VT-1161) role as a selective CYP51 inhibitor with minimal CYP3A4 interaction, providing insights for optimizing antifungal research design and clinical safety.